Related Experiment Video
Updated: Sep 9, 2025
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
Antibody and B-Cell Responses to PHH-1V81 XBB.1.16-Adapted SARS-CoV-2 Booster Vaccination Are Associated With Variant
Cèlia Torres1,2, Alfons Jiménez1,2, Meritxell Deulofeu3
1ISGlobal, Barcelona, Spain.
Abstract:
Immune escape by SARS-CoV-2 emerging variants jeopardizes vaccine effectiveness, necessitating new immunization strategies. Here, we assessed the antibody B-cell response in 40 individuals receiving either the PHH-1V81 XBB.1.16- or BNT162b2 XBB.1.5-adapted vaccine boosters. Both immunizations significantly increased ancestral-reactive B cells cross-recognizing the vaccine variant. Notably, XBB.1.16 cross-reactive B cells were associated with neutralizing responses, reinforcing the potential of PHH-1V81 as a strong boosting candidate against emerging variants.
Related Concept Videos
00:42Cross-reactivity
01:24B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:36Humoral Immune Responses
01:51Vaccinations
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:26Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...